$3.34T
Total marketcap
$172.5B
Total volume
BTC 56.97%     ETH 12.06%
Dominance

Corcept Therapeutics Incorporated CORT Stock

$37.50   2.655360%
Add to favorites
Market Cap
$7.40B
LOW - HIGH [24H]
$69.91 - $79.75
VOLUME [24H]
$716.77K
P/E Ratio
80.68
Earnings per share
$0.87
Price   Prediction

Corcept Therapeutics Incorporated Price Chart

Sorry, that's all we've gotfor now...

Corcept Therapeutics Incorporated CORT Financial and Trading Overview

Corcept Therapeutics Incorporated stock price 37.5 USD
Previous Close {summary_details__previousClose}
Open {summary_details__open}
Bid {summary_details__bid} x {summary_details__bidSize}
Ask {summary_details__ask} x {summary_details__askSize}
Day's Range 22.63 - 23.2 USD
52 Week Range 17.86 - 30.14 USD
Volume {summary_details__volume}
Avg. Volume {summary_details__averageVolume}
Market Cap {summary_details__marketCap}
Beta (5Y Monthly) {summary_details__beta}
PE Ratio (TTM) {summary_details__trailingPE}
EPS (TTM) 0.87 USD
Forward Dividend & Yield {summary_details__dividendRate} ({summary_details__dividendYield})
Ex-Dividend Date {summary_details__exDividendDate}
1y Target Est {financial_data__targetMeanPrice}

CORT Valuation Measures

Enterprise Value {default_key_statistics__enterpriseValue}
Trailing P/E {summary_details__trailingPE}
Forward P/E {summary_details__forwardPE}
PEG Ratio (5 yr expected) {default_key_statistics__pegRatio}
Price/Sales (ttm) {summary_details__priceToSalesTrailing12Months}
Price/Book (mrq) {default_key_statistics__priceToBook}
Enterprise Value/Revenue {default_key_statistics__enterpriseToRevenue}
Enterprise Value/EBITDA {default_key_statistics__enterpriseToEbitda}

Trading Information

Corcept Therapeutics Incorporated Stock Price History

Beta (5Y Monthly) {default_key_statistics__beta}
52-Week Change {default_key_statistics__52WeekChange}
S&P500 52-Week Change {default_key_statistics__SandP52WeekChange}
52 Week High {summary_details__fiftyTwoWeekHigh}
52 Week Low {summary_details__fiftyTwoWeekLow}
50-Day Moving Average {summary_details__fiftyDayAverage}
200-Day Moving Average {summary_details__twoHundredDayAverage}

CORT Share Statistics

Avg. Volume (3 month) {summary_details__averageVolume}
Avg. Daily Volume (10-Days) {summary_details__averageDailyVolume10Day}
Shares Outstanding {default_key_statistics__sharesOutstanding}
Float {default_key_statistics__floatShares}
Short Ratio {default_key_statistics__shortRatio}
% Held by Insiders {default_key_statistics__heldPercentInsiders}
% Held by Institutions {default_key_statistics__heldPercentInstitutions}
Shares Short {default_key_statistics__sharesShort}
Short % of Float {default_key_statistics__shortPercentOfFloat}
Short % of Shares Outstanding {default_key_statistics__sharesPercentSharesOut}

Dividends & Splits

Trailing Annual Dividend Rate {summary_details__trailingAnnualDividendRate}
Trailing Annual Dividend Yield {summary_details__trailingAnnualDividendYield}
5 Year Average Dividend Yield {summary_details__fiveYearAvgDividendYield}
Payout Ratio {summary_details__payoutRatio}
Last Split Factor {default_key_statistics__lastSplitFactor}

Financial Highlights

Fiscal Year

Fiscal Year Ends {default_key_statistics__lastFiscalYearEnd}
Most Recent Quarter (mrq) {default_key_statistics__mostRecentQuarter}
Next Fiscal Year End {default_key_statistics__nextFiscalYearEnd}

Profitability

Profit Margin {financial_data__profitMargins}
Operating Margin (ttm) {financial_data__operatingMargins}
Gross Margin {financial_data__grossMargins}
EBITDA Margin {financial_data__ebitdaMargins}

Management Effectiveness

Return on Assets (ttm) {financial_data__returnOnAssets}
Return on Equity (ttm) {financial_data__returnOnEquity}

Income Statement

Revenue (ttm) {financial_data__totalRevenue}
Revenue Per Share (ttm) {financial_data__revenuePerShare}
Quarterly Revenue Growth (yoy) {financial_data__revenueGrowth}
Gross Profit (ttm) {financial_data__grossProfits}
EBITDA {financial_data__ebitda}
Net Income Avi to Common (ttm) {default_key_statistics__netIncomeToCommon}
Diluted EPS (ttm) {default_key_statistics__trailingEps}
Quarterly Earnings Growth (yoy) {default_key_statistics__earningsQuarterlyGrowth}

Balance Sheet

Total Cash (mrq) {financial_data__totalCash}
Total Cash Per Share (mrq) {financial_data__totalCashPerShare}
Total Debt (mrq) {financial_data__totalDebt}
Total Debt/Equity (mrq) {financial_data__debtToEquity}
Current Ratio (mrq) {financial_data__currentRatio}
Book Value Per Share (mrq) {default_key_statistics__bookValue}

Cash Flow Statement

Operating Cash Flow (ttm) {financial_data__operatingCashflow}
Levered Free Cash Flow (ttm) {financial_data__freeCashflow}

Profile of Corcept Therapeutics Incorporated

Country United States
State {summary_profile__state}
City {summary_profile__city}
Address {summary_profile__address1}
ZIP {summary_profile__zip}
Phone {summary_profile__phone}
Website {summary_profile__website}
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees {summary_profile__fullTimeEmployees}

{summary_profile__longBusinessSummary}

Q&A For Corcept Therapeutics Incorporated Stock

What is a current CORT stock price?

Corcept Therapeutics Incorporated CORT stock price today per share is 37.5 USD.

How to purchase Corcept Therapeutics Incorporated stock?

You can buy CORT shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Corcept Therapeutics Incorporated?

The stock symbol or ticker of Corcept Therapeutics Incorporated is CORT.

Which industry does the Corcept Therapeutics Incorporated company belong to?

The Corcept Therapeutics Incorporated industry is Biotechnology.

How many shares does Corcept Therapeutics Incorporated have in circulation?

The max supply of Corcept Therapeutics Incorporated shares is 197.24M.

What is Corcept Therapeutics Incorporated Price to Earnings Ratio (PE Ratio)?

Corcept Therapeutics Incorporated PE Ratio is 80.68391000 now.

What was Corcept Therapeutics Incorporated earnings per share over the trailing 12 months (TTM)?

Corcept Therapeutics Incorporated EPS is 0.87 USD over the trailing 12 months.

Which sector does the Corcept Therapeutics Incorporated company belong to?

The Corcept Therapeutics Incorporated sector is Healthcare.

Corcept Therapeutics Incorporated CORT included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
US Tech Composite IXIC 23419.08 USD
-0.24
6.09B USD 23414.83 USD 23521.05 USD 6.09B USD
US Tech Composite Total Return XCMP 28797.52 USD
-0.24
28792.3 USD 28922.91 USD
US Tech US 700 Small Cap Index NQUS700SC 2634.68 USD
-0.65
2634.56 USD 2652.33 USD
US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG 3497.11 USD
-0.57
3496.6 USD 3518.91 USD
US Tech Health Care IXHC 1187.51 USD
-0.86
1185.41 USD 1195.34 USD
US Tech Global BuyBack Achievers DRBG 2805.16 USD
+0.14
2801.35 USD 2810.72 USD
US Tech Capital Market Composite RCMP 127.02 USD
-1.28
127.01 USD 129.65 USD
US Tech US Smart Pharmaceuticals NQSSPH 1765.99 USD
-0.66
1762.18 USD 1776.43 USD
US Tech US BuyBack Achievers Sel DRBS 2340.09 USD
+0.42
2336.31 USD 2349.71 USD
✨New! Portfolio🚀